Figure 4.
Forest plot NAFLD prevalence in patients with type 1 diabetes, subgroups according to diagnostic modality: (1) ultrasound, (2) MRI, (3) biopsy, (4) combination non-invasive risk score and TE. NAFLD+, patients with nonalcoholic fatty liver disease; T1DM, type 1 diabetes mellitus; MRI, magnetic resonance imaging; TE, transient elastography.